ATE432943T1 - Einschlusskörper als antigene für die orale impfung von tieren gegen csfv - Google Patents

Einschlusskörper als antigene für die orale impfung von tieren gegen csfv

Info

Publication number
ATE432943T1
ATE432943T1 AT03789658T AT03789658T ATE432943T1 AT E432943 T1 ATE432943 T1 AT E432943T1 AT 03789658 T AT03789658 T AT 03789658T AT 03789658 T AT03789658 T AT 03789658T AT E432943 T1 ATE432943 T1 AT E432943T1
Authority
AT
Austria
Prior art keywords
antigens
inclusion body
animals against
oral vaccination
against csfv
Prior art date
Application number
AT03789658T
Other languages
English (en)
Inventor
Andrzej Plucienniczak
Violetta Saczynska
Malgorzata Kesik
Anna Porebska
Boguslaw Szewczyk
Jolanta Ficinska
Original Assignee
Inst Biotechnologii I Antybiot
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Biotechnologii I Antybiot filed Critical Inst Biotechnologii I Antybiot
Application granted granted Critical
Publication of ATE432943T1 publication Critical patent/ATE432943T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT03789658T 2002-12-31 2003-12-31 Einschlusskörper als antigene für die orale impfung von tieren gegen csfv ATE432943T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL358082A PL199190B1 (pl) 2002-12-31 2002-12-31 Ciałka inkluzyjne jako antygeny do pokarmowej immunizacji zwierząt
PCT/PL2003/000152 WO2004058806A2 (en) 2002-12-31 2003-12-31 Inclusion bodies as antigens for the oral vaccination of animals against csfv

Publications (1)

Publication Number Publication Date
ATE432943T1 true ATE432943T1 (de) 2009-06-15

Family

ID=32678128

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03789658T ATE432943T1 (de) 2002-12-31 2003-12-31 Einschlusskörper als antigene für die orale impfung von tieren gegen csfv

Country Status (7)

Country Link
EP (1) EP1603938B1 (de)
AT (1) ATE432943T1 (de)
AU (1) AU2003294192A1 (de)
DE (1) DE60327896D1 (de)
ES (1) ES2328350T3 (de)
PL (1) PL199190B1 (de)
WO (1) WO2004058806A2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116655751A (zh) * 2016-08-01 2023-08-29 浙江海隆生物科技有限公司 重组猪瘟e2蛋白及其亚单位疫苗的制备方法和应用
CN107619435B (zh) * 2017-09-19 2021-03-16 中国农业科学院上海兽医研究所 一种猪瘟病毒e2蛋白的抗原表位、抗体的制备及应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA901719B (en) * 1989-03-19 1991-01-30 Akzo Nv Hog cholera virus vaccine and diagnostics
WO2003013598A2 (en) * 2001-08-09 2003-02-20 Lam Dominic M K Novel vaccine compositions and methods of vaccine preparation for veterinary and human diseases

Also Published As

Publication number Publication date
PL199190B1 (pl) 2008-08-29
WO2004058806A2 (en) 2004-07-15
PL358082A1 (en) 2004-07-12
AU2003294192A1 (en) 2004-07-22
EP1603938A2 (de) 2005-12-14
ES2328350T3 (es) 2009-11-12
WO2004058806A3 (en) 2004-10-28
DE60327896D1 (de) 2009-07-16
AU2003294192A8 (en) 2004-07-22
EP1603938B1 (de) 2009-06-03

Similar Documents

Publication Publication Date Title
EA201301072A1 (ru) Антитела против il-23p19 и их применение
BRPI0417823A (pt) métodos para uso de bifidobactérias probióticas para animais de estimação
NO20054078D0 (no) Humane antistoffer spesifikke for Interleukin 15 (IL15).
NO20083895L (no) Anti-IGF-1R human monoklonalantibody formulering
ATE461217T1 (de) Glp-1-verbindungen
SG163598A1 (en) Lawsonia vaccine and methods of use thereof
EA200801427A1 (ru) Молекулы антитела со специфической активностью в отношении интерлейкина-6 (ил-6) человека
DE60311477D1 (de) Vertikales stentschneidsystem
DE602004020189D1 (de) Adjuvante influenza-vakzine
NO20052149D0 (no) Vaksine.
CY1110130T1 (el) Παραγωγα μορφολινης για χρηση ως αγωνιστες ντοπαμινης στην θεραπευτικη αγωγη σεξουαλικης δυσλειτουργιας i.α.
CY1112575T1 (el) Βελτιωμενα αδρανοποιημενα εμβολια fcv
BRPI0406628A (pt) Determinados compostos de fosfato de aminoalquil glucosaminida e seu uso
EA200602154A1 (ru) Пиридин-4-илэтинилимидазолы и -пиразолы как антагонисты рецептора mglu5
BR0208896A (pt) Vacina contra o vìrus da febre do nilo
DK1713438T3 (da) Medicinsk sæbe
ATE432943T1 (de) Einschlusskörper als antigene für die orale impfung von tieren gegen csfv
HUP0401077A2 (hu) Mycoplasma bovis fertőzési modell, valamint eljárások M. bovis bejuttatására és tüdőgyulladásos tüdőléziók indukálására
EA200700017A1 (ru) Способ усиления иммунного ответа на вакцину
EA200600382A1 (ru) Коллагеновый гидролизат
ATE388962T1 (de) Einschlusskörper für die mündliche impfung von tieren
DE602005003922D1 (de) Synthese von spongosin
WO2004073604A3 (en) Dna vaccines that express an adp-ribosyltransferase toxin devoid of adp-ribosyltransferase activity
EP1578353A4 (de) Anwendungsverfahren und zusammensetzungen zur diagnose und behandlung von infektionskrankheiten
RU2001103770A (ru) Способ снижения уровня тревожности у лабораторных животных в эксперименте

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties